drugset
Drugs / Psoralen
last change Jun 2026 re-read 2 minutes ago

Psoralen

also known as Ficusin · NSC-404562

Small molecule

Developed for
generalized vitiligo
Investigated by
Hayat Abad Medical Complex, Peshawar

Trials 1 · a red edge is where a trial was stopped

today NCT07055529 · Ph 0
2027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 0 NCT07055529 Jun → Dec 2026 expected generalized vitiligo Hayat Abad Medical Complex, Peshawar Not yet recruiting No outcome recorded
Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT00005092 Background May 1999 → Aug 2002 leukemia, myelodysplastic syndrome, plasma cell neoplasm M.D. Anderson Cancer Center Completed No outcome recorded

Evidence & citations 5 cited values

Every value below carries the sentence it was read from. 3 sources stand behind the page.

FieldValueCited text
Known as Psoralen “For many years, PUVA (oral Psoralen plus ultraviolet A) therapy has been used to treat generalized vitiligo.” NCT07055529 ↗
1

NCT00005092 ↗
Known as Ficusin ChEMBL registry synonym — accepted as the source's own label CHEMBL164660 ↗
Known as NSC-404562 ChEMBL registry synonym — accepted as the source's own label CHEMBL164660 ↗
Modality Small molecule — CHEMBL164660 ↗
Route Oral “PUVA (oral Psoralen plus ultraviolet A) therapy” NCT07055529 ↗